They inform biological hypotheses but do not establish clinical efficacy in humans

Who Should NOT Consider Peptides Based on current evidence, I would advise against peptide use in the following individuals: Anyone with a current or recent cancer diagnosis Anyone with a strong family history of hormone-sensitive cancers (breast, ovarian, uterine, prostate, colorectal) Anyone with genetic mutations predisposing to cancer (BRCA1/2, Lynch syndrome, etc.) Anyone with active autoimmune disease or severe inflammatory conditions Pregnant or breastfeeding women Anyone who has not established foundational health practices Competitive athletes (most peptides are banned substances) Anyone seeking a "quick fix" rather than commitment to comprehensive health optimization If Considering Peptides: A Cautious Approach For patients who have established solid foundations, have no contraindications, understand the limitations of current evidence, and wish to explore peptides as a potential adjunct, here is the approach I might considerwith significant caveats: Lower-Risk Starting Point Topical GHK-Cu: This has the most established safety profile and documented benefits for skin health

Was Studien ber GHK-Cu zeigen und wie diese Ergebnisse realistisch einzuordnen sind
It is well known that when patients are treated with hydroxocobalamin, an equilibrium exists in the human body between the forms of vitamin B12: hydroxocobalamin and aquacobalamin in lymph and other body fluids
Does the supplier publish a per-lot certificate rather than a catalog-wide claim
In fact, cosmetic scientists who specialise in developing retinol formulas are quick to disprove this and we've asked around a lot